Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05998330 · ClinicalTrials.gov registry record · NA
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
A NA study of Cirrhosis and Cirrhosis, Liver, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05998330: Recruiting NA study of Cirrhosis and Cirrhosis, Liver, sponsored by Massachusetts General Hospital.
NCT05998330 is a NA study of Cirrhosis and Cirrhosis, Liver that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 200 participants, below the 90,405-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05998330, a NA study of Cirrhosis and Cirrhosis, Liver, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate whether early integration of palliative care in the care of hospitalized patients with advanced liver disease (AdvLD) can improve patients' quality of life, physical symptoms, mood, and serious illness communication. Palliative care is a medical specialty focused on lessening (or "palliating") symptoms and assisting in coping with serious illness.
Primary Outcome
Compare patient quality of life (FACIT-Pal) scores up to 4 weeks adjusting for baseline quality of life scores between the study arms. Score range 0-184 with higher scores indicating better quality of life.
Conditions Studied
Interventions
- BEHAVIORAL LiverPAL
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-09-20 |
| Est. Completion | 2027-07 |
| Phase | NA |
What NCT05998330 shows while recruiting
NCT05998330 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 90,405-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower).
The record links to 5 conditions, with Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which LiverPAL is the first listed.
NCT05998330 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05998330 about?
NCT05998330 is a clinical study titled "LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease". The goal of this clinical trial is to evaluate whether early integration of palliative care in the care of hospitalized patients with advanced liver disease (AdvLD) can improve patients' quality of life, physical symptoms, mood, and serious illness communication. Palliative care is a medical special...
What is the current status of trial NCT05998330?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-09-20. Estimated completion is 2027-07.
What conditions does trial NCT05998330 study?
This clinical trial studies the following conditions: Cirrhosis, Cirrhosis, Liver, End Stage Liver DIsease, Liver Disease Chronic, Advanced Cirrhosis.
What interventions are being tested in trial NCT05998330?
The interventions under investigation include: LiverPAL (BEHAVIORAL).
Who is sponsoring clinical trial NCT05998330?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05998330 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05998330's enrollment target sits among peer trials
200 13th of 53 higher than 41 of 53 other Cirrhosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cirrhosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
-
Copper Supplementation in Cirrhosis
RECRUITING · NA
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
CirrhosisRx CDS System
RECRUITING · NA
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI